IPO
-
-
-
-
-
-
-
Legend Biotech Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Highlights
-
-
-
-
-
-
-
Legend Biotech Reports First Quarter 2021 Financial Results and Recent Highlights
-
-
-
-
-
-
-
Legend Biotech Names Current Chief Financial Officer, Ying Huang, as Interim CEO
-
-
-
-
-
-
-
Legend Biotech Corporation (LEGN) Opens at $37, IPO Priced at $23
-
-
118,853 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

